Corporate Governance codes and practices

• Healthcare Professionals
•  
• Patients
•  
• Investors
•  
• Media
•  
• R&D
•  
• Jobs
•  
• Sustainability
•  
• About us
•  

• Novo Nordisk in brief
• Novo Nordisk way of management
• Management
• Corporate governance
  • Governance model
  • Shareholder Rights
  • Novo Nordisk Foundation
  • General meetings and Shareholders meeting
  • Board of Directors
  • Chairmanship and board committees
  • Audit Committee
  • Executive Management
  • Remuneration policy
  • Self-assessment
  • Risk management
  • Internal control
  • Assurance
  • Audit
  • Benchmark 2007
  • Codes and practices
• Global offices
• Changing diabetes
• Changing possibilities in haemophilia
• Download centre
• Contact us

• Rate this page
• Bookmark and Share
• Print

Corporate governance codes and practices

Novo Nordisk is in full compliance with the Danish Corporate Governance Recommendations designated by NASDAQ OMX Copenhagen, and is - as a foreign listed issuer - in general in compliance with the corporate governance standards on New York and London Stock Exchanges where the Novo Nordisk B shares and ADRs, respectively, are listed.

For a detailed review of Novo Nordisk's compliance with and deviations from the applicable codes please see the following:

• Danish Corporate Governance Recommendations (2008) - NASDAQ OMX Copenhagen
• Corporate Governance Standards (2008) - New York Stock Exchange
• The Combined Code (2008) - London Stock Exchange

Back to top